China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving market approval from the National Medical Products Administration (NMPA) for its intracranial PTA balloon NEO-Skater, designed to improve blood flow perfusion in atherosclerotic intracranial vessels.
NEO-Skater: Innovative Design and Benefits
NEO-Skater features an improved lubrication coating on the catheter platform and balloon, allowing for smooth passage through the tortuous and narrow vascular environment. This innovation enhances the device’s ability to navigate complex intracranial pathways, improving treatment outcomes for patients with atherosclerotic conditions.-Fineline Info & Tech
